Skip to search formSkip to main contentSkip to account menu

Viscumin

Known as: ML-I protein, Viscum album, ML1 protein, Viscum album, mistletoe lectin I 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Cancer is the leading cause of death in industrialized countries. Cancer therapy often involves monoclonal antibodies or small… 
2007
2007
BackgroundPreparations of mistletoe (Viscum album) are the form of cancer treatment that is most frequently used in the… 
Highly Cited
2003
Highly Cited
2003
The X-ray structure of mistletoe lectin I (MLI), a type-II ribosome-inactivating protein (RIP), cocrystallized with galactose is… 
2002
2002
Ricin and viscumin are heterodimeric protein toxins. Their A-chain is enzymatically active and removes an adenine residue from… 
Highly Cited
1999
Highly Cited
1999
Mistletoe lectin I (MLI) is the major active constituent of mistletoe extracts, which are widely used for adjuvant tumour therapy… 
1997
1997
The effects of mistletoe lectin I (ML I) on the human T-cell leukemia line MOLT-4, the monocytic line THP-1 and on human… 
Review
1986
Review
1986
Mistletoe lectins are of high biological activity. The mistletoe lectin I (ML I) is a naturally occurring conjugate of an enzyme…